BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 23365259)

  • 1. Effect of reconstruction parameters in high-definition PET/CT on assessment of lymph node metastases in head and neck squamous cell carcinoma.
    Sadick M; Molina F; Frey S; Piniol R; Sadick H; Brade J; Fink C; Schoenberg SO; He Y
    J Nucl Med Technol; 2013 Mar; 41(1):19-25. PubMed ID: 23365259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
    Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M
    J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma.
    Wagner A; Schicho K; Glaser C; Zettinig G; Yerit K; Lang S; Klug C; Leitha T
    J Craniomaxillofac Surg; 2004 Dec; 32(6):343-9. PubMed ID: 15555515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
    Lee SH; Huh SH; Jin SM; Rho YS; Yoon DY; Park CH
    Otolaryngol Head Neck Surg; 2012 Oct; 147(4):692-8. PubMed ID: 22535915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of preoperative 18F-FDG PET/CT for the assessing contralateral neck in head and neck cancer patients with unilateral node metastasis (N1-3).
    Joo YH; Yoo IR; Cho KJ; Park JO; Nam IC; Kim CS; Kim SY; Kim MS
    Clin Otolaryngol; 2014 Dec; 39(6):338-44. PubMed ID: 25102759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of partial volume correction in staging of head and neck squamous cell carcinoma using PET/CT.
    Fayad H; Le Pogam A; Lamare F; Fernandez P; Pradier O; Valette G; Visvikis D; Cheze Le Rest C
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):319-28. PubMed ID: 25265252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
    Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
    J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External ultrasonography of the neck does not add diagnostic value to integrated positron emission tomography-computed tomography (PET-CT) scanning in the diagnosis of cervical lymph node metastases in patients with esophageal carcinoma.
    Blom RL; Vliegen RF; Schreurs WM; Belgers HJ; Stohr I; Oostenbrug LE; Sosef MN
    Dis Esophagus; 2012 Aug; 25(6):555-9. PubMed ID: 22150869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimised PET reconstruction of the head and neck area: improved diagnostic accuracy.
    Vogel WV; Wensing BM; van Dalen JA; Krabbe PF; van den Hoogen FJ; Oyen WJ
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1276-82. PubMed ID: 16025276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m-MIBI in primary and recurrent head and neck tumors: contribution of bone SPECT image fusion.
    Leitha T; Glaser C; Pruckmayer M; Rasse M; Millesi W; Lang S; Nasel C; Backfrieder W; Kainberger F
    J Nucl Med; 1998 Jul; 39(7):1166-71. PubMed ID: 9669388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.
    Carlson ER; Schaefferkoetter J; Townsend D; McCoy JM; Campbell PD; Long M
    J Oral Maxillofac Surg; 2013 Jan; 71(1):162-77. PubMed ID: 22742956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
    Troost EG; Vogel WV; Merkx MA; Slootweg PJ; Marres HA; Peeters WJ; Bussink J; van der Kogel AJ; Oyen WJ; Kaanders JH
    J Nucl Med; 2007 May; 48(5):726-35. PubMed ID: 17475960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer.
    Yamazaki Y; Saitoh M; Notani K; Tei K; Totsuka Y; Takinami S; Kanegae K; Inubushi M; Tamaki N; Kitagawa Y
    Ann Nucl Med; 2008 Apr; 22(3):177-84. PubMed ID: 18498032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer.
    Adams S; Baum RP; Stuckensen T; Bitter K; Hör G
    Eur J Nucl Med; 1998 Sep; 25(9):1255-60. PubMed ID: 9724374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in PET/CT image quality with a combination of point-spread function and time-of-flight in relation to reconstruction parameters.
    Akamatsu G; Ishikawa K; Mitsumoto K; Taniguchi T; Ohya N; Baba S; Abe K; Sasaki M
    J Nucl Med; 2012 Nov; 53(11):1716-22. PubMed ID: 22952340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
    Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M
    Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
    Schwartz DL; Ford E; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellyn B; Mattes D; Meyer J; Phillips M; Leblanc M; Kinahan P; Krohn K; Eary J; Laramore GE
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):129-36. PubMed ID: 15629603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of (11)C-choline PET/CT and enhanced CT in the evaluation of patients with pulmonary abnormalities and locoregional lymph node involvement in lung cancer.
    Peng Z; Liu Q; Li M; Han M; Yao S; Liu Q
    Clin Lung Cancer; 2012 Jul; 13(4):312-20. PubMed ID: 22182444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.